Food and Drug Administration

Cardiovascular and Renal Drugs Advisory Committee

December 8, 2003

Bayer HealthCare's Citizen Petition for Expanded Aspirin Professional Labeling to Include Moderate Risk Patients, Erica Peitler, RPh, Bayer HealthCare LLC (HTM) (PPT)

Regulatory Histpry of Aspirin, Dr. Michelle Jackson, PhD, FDA (HTM) (PPT)

Issues With the Statistical Analyses in the Citizen's Petition for Aspirin on Reduction of the Risk of 1st MI, Dr. Chenxiong (Charles) Le, PhD, FDA (HTM) (PPT)

Open Public Hearing

Presentation by Dr. Eric Topol, MD, The Cleveland Clinic Foundation (PDF)

Statement of the Preventive Cardiovascular Nurses Association, Suzanne Hughes, RN, MSN (PDF)

Statement of the American Heart Association (PDF)